158 related articles for article (PubMed ID: 9717983)
1. Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).
Itoh M; Uchimura K; Hayakawa N; Makino M; Hayashi R; Nagata M; Kakizawa H; Nagasaka A; Sakamoto H; Kuzuya H
Clin Exp Immunol; 1998 Aug; 113(2):309-14. PubMed ID: 9717983
[TBL] [Abstract][Full Text] [Related]
2. Distinctive response of thyroid-infiltrating mononuclear cells to B cell activation through CD40 and interleukin-4 in Graves' patients.
Itoh M; Uchimura K; Yamamoto K; Makino M; Imamura S; Kobayashi T; Fujiwara K; Kato T; Hayakawa N; Sawai Y; Nagasaka A; Iwase K; Nomura T; Hagino Y
Cytokine; 2002 Aug; 19(3):107-14. PubMed ID: 12242076
[TBL] [Abstract][Full Text] [Related]
3. The effects of CD40- and interleukin (IL-4)-activated CD23+ cells on the production of IL-10 by mononuclear cells in Graves' disease: the role of CD8+ cells.
Uchimura K; Itoh M; Yamamoto K; Imamura S; Makino M; Kato T; Fujiwara K; Sawai Y
Clin Exp Immunol; 2002 May; 128(2):308-12. PubMed ID: 11985521
[TBL] [Abstract][Full Text] [Related]
4. Production of IL-10 and IL-12 in CD40 and interleukin 4-activated mononuclear cells from patients with Graves' disease.
Itoh M; Uchimura K; Makino M; Kobayashi T; Hayashi R; Nagata M; Kakizawa H; Fujiwara K; Nagasaka A
Cytokine; 2000 Jun; 12(6):688-93. PubMed ID: 10843746
[TBL] [Abstract][Full Text] [Related]
5. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
[TBL] [Abstract][Full Text] [Related]
6. IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency.
Punnonen J; Kainulainen L; Ruuskanen O; Nikoskelainen J; Arvilommi H
Scand J Immunol; 1997 Feb; 45(2):203-12. PubMed ID: 9042433
[TBL] [Abstract][Full Text] [Related]
7. Study of induction of activation of human peripheral blood mononuclear cells with a non-activating form of anti-CD3 MoAb in autoimmune thyroid disease (AITD).
Resetkova E; Arreaza G; Yoshikawa N; Morita T; Kim H; Carayon P; Volpé R
Clin Exp Immunol; 1993 Mar; 91(3):397-403. PubMed ID: 8443962
[TBL] [Abstract][Full Text] [Related]
8. Effect of interleukin-10 on anti-CD40- and interleukin-4-induced immunoglobulin E production by human lymphocytes.
Uejima Y; Takahashi K; Komoriya K; Kurozumi S; Ochs HD
Int Arch Allergy Immunol; 1996 Jul; 110(3):225-32. PubMed ID: 8688668
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of T lymphocytes to thyroglobulin and thyroperoxidase in autoimmune thyroid diseases.
Akasu F; Morita T; Resetkova E; Yoshikawa N; Carayon P; Volpé R
Autoimmunity; 1993; 14(4):261-8. PubMed ID: 8102254
[TBL] [Abstract][Full Text] [Related]
10. The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease.
Yoshikawa N; Morita T; Arreaza G; Resetkova E; Mukuta T; Volpé R
Clin Invest Med; 1995 Apr; 18(2):91-8. PubMed ID: 7788961
[TBL] [Abstract][Full Text] [Related]
11. Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4.
Chomarat P; Briolay J; Banchereau J; Miossec P
Arthritis Rheum; 1993 Feb; 36(2):234-42. PubMed ID: 8431213
[TBL] [Abstract][Full Text] [Related]
12. Activation of T lymphocyte subsets by synthetic TSH receptor peptides and recombinant glutamate decarboxylase in autoimmune thyroid disease and insulin-dependent diabetes.
Mukuta T; Yoshikawa N; Arreaza G; Resetkova E; Leushner J; Song YH; Akasu F; Onaya T; Volpé R
J Clin Endocrinol Metab; 1995 Apr; 80(4):1264-72. PubMed ID: 7714099
[TBL] [Abstract][Full Text] [Related]
13. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
[TBL] [Abstract][Full Text] [Related]
14. Epitope-dependent synergism and antagonism between CD40 antibodies and soluble CD40 ligand for the regulation of CD23 expression and IgE synthesis in human B cells.
Challa A; Pound JD; Armitage RJ; Gordon J
Allergy; 1999 Jun; 54(6):576-83. PubMed ID: 10435471
[TBL] [Abstract][Full Text] [Related]
15. Release of cytokines and soluble cell surface molecules by PBMC after activation with the bispecific antibody CD3 x CD19.
Klein SC; Boer LH; de Weger RA; de Gast GC; Bast EJ
Scand J Immunol; 1997 Nov; 46(5):452-8. PubMed ID: 9393627
[TBL] [Abstract][Full Text] [Related]
16. IL-14 and IL-16 are expressed in the thyroid of patients with either Graves' disease or Hashimoto's thyroiditis.
Kemp EH; Ajjan RA; Metcalfe RA; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 2015 Nov; 83(5):726-32. PubMed ID: 25940130
[TBL] [Abstract][Full Text] [Related]
17. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
Chan JY; Walfish PG
Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of CD23 hyperexpression on B cells from patients with rheumatoid arthritis.
De Miguel S; Galocha B; Jover JA; Bañares A; Hernández-García C; García-Asenjo JA; Fernández-Gutiérrez B
J Rheumatol; 2001 Jun; 28(6):1222-8. PubMed ID: 11409113
[TBL] [Abstract][Full Text] [Related]
19. Soluble forms of CD40 inhibit biologic responses of human B cells.
Fanslow WC; Anderson DM; Grabstein KH; Clark EA; Cosman D; Armitage RJ
J Immunol; 1992 Jul; 149(2):655-60. PubMed ID: 1378075
[TBL] [Abstract][Full Text] [Related]
20. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases.
Watanabe M; Amino N; Hochito K; Watanabe K; Kuma K; Iwatani Y
Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
